CYPRIUM THERAPEUTICS Trademark

Trademark Overview

On Wednesday, March 15, 2017, a trademark application was filed for CYPRIUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CYPRIUM THERAPEUTICS trademark a serial number of 87372166. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by Cyprium Therapeutics, Inc.. The CYPRIUM THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Pharmaceutical preparations for human use for the treatment of diseases and disorders where copper deficiency is present; Pharmaceutical preparations for human use for the treatment of hematological and neurological disorders
cyprium therapeutics

General Information

Serial Number87372166
Word MarkCYPRIUM THERAPEUTICS
Filing DateWednesday, March 15, 2017
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6341812
Registration DateTuesday, May 4, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for human use for the treatment of Menkes disease and copper transport and metabolism diseases and disorders; Pharmaceutical preparations for human use for the treatment of diseases and disorders where copper deficiency is present; Pharmaceutical preparations for human use for the treatment of hematological and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 21, 2017
Primary Code005
First Use Anywhere DateFriday, January 25, 2019
First Use In Commerce DateFriday, January 25, 2019

Trademark Owner History

Party NameCyprium Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCyprium Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameCyprium Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, March 27, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 26, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, March 15, 2021USE AMENDMENT FILED
Monday, March 15, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, October 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2020EXTENSION 5 GRANTED
Thursday, October 8, 2020EXTENSION 5 FILED
Thursday, October 8, 2020TEAS EXTENSION RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020EXTENSION 4 GRANTED
Wednesday, April 8, 2020EXTENSION 4 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Monday, October 14, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2019EXTENSION 3 GRANTED
Thursday, October 10, 2019EXTENSION 3 FILED
Thursday, October 10, 2019TEAS EXTENSION RECEIVED
Tuesday, March 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2019EXTENSION 2 GRANTED
Friday, March 15, 2019EXTENSION 2 FILED
Friday, March 15, 2019TEAS EXTENSION RECEIVED
Friday, October 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 26, 2018CORRECTED NOA E-MAILED
Thursday, October 25, 2018EXTENSION 1 GRANTED
Monday, September 24, 2018EXTENSION 1 FILED
Thursday, October 25, 2018DIVISIONAL PROCESSING COMPLETE
Monday, September 24, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, September 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 24, 2018TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 24, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2018NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2018NON-FINAL ACTION WRITTEN
Thursday, December 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2017NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2017NON-FINAL ACTION WRITTEN
Thursday, June 8, 2017ASSIGNED TO EXAMINER
Tuesday, March 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics cyprium pharmaceutical disorders treatment preparations human copper diseases present hematological neurological